EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epinephrine as an Adjuvant to Ropivacaine for Erector Spinae Plane Block in Lumbar Spine Surgery: A Randomized, Double-Blind, Controlled Trial

Masoud Nashibi, Sogol Asgari, Kamran Mottaghi, Hasan Ali Ahmadi, Maryam Moghbel, Shiva Pourakbari, Sam Hosseininasab

Archives of Neuroscience · 31.07.2026 · 13 (3)

DOI: 10.5812/ans-175329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Neuroscience, online erschienen am 31.07.2026. Verfasst von Masoud Nashibi und 6 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The erector spinae plane block (ESPB) alleviates postoperative pain after lumbar spine surgery, but the optimal local anesthetic formulation has not been established. Epinephrine prolongs the duration of peripheral nerve blocks through vasoconstriction; however, its utility when combined with ropivacaine for ESPB in lumbar surgery has not been examined.

Objectives

To determine whether adding epinephrine to ropivacaine for ESPB improves early analgesia and reduces perioperative opioid and anaesthetic requirements.

Methods

In this double-blind randomised controlled trial, 66 patients were randomised, and 61 were analysed (30 control, 31 intervention) after five post-randomisation exclusions (two cancelled surgeries, one anatomical limitation preventing bilateral ESPB, and two anaesthetic protocol deviations). Patients undergoing elective 1- to 3-level lumbar surgery received bilateral ultrasound-guided ESPB with 0.25% ropivacaine alone or with epinephrine 5 μg·mL-1 (100 μg per side; 200 μg bilaterally). The primary endpoint was pain in the post-anaesthesia care unit (PACU), measured using the Numeric Rating Scale, which was scored from 0 to 10; pain was interpreted against a prespecified minimal clinically important difference (MCID) of 1.5 - 2 points. Secondary endpoints were 12-hour pain, intraoperative fentanyl and isoflurane consumption, time to first opioid request, and blood loss. Mann–Whitney U tests with Hodges–Lehmann median differences were used, and linear regression was used for adjustment. Time to first opioid request was analysed as a continuous outcome over 24 hours; no time-to-event analysis was performed. Analyses followed a modified intention-to-treat principle; this was not a full intention-to-treat analysis, and post-randomisation exclusion bias is acknowledged.

Results

Pain in the PACU was lower with epinephrine (P = 0.0038; r = 0.42), but the 1-point reduction was below the prespecified MCID; by this criterion, the trial was negative for a clinically important primary endpoint. The fully adjusted estimate was β = −1.250 (95% confidence interval [CI] −2.47 to −0.028; P = 0.045), with a wide confidence interval approaching the null. Pain at 12 hours was higher with epinephrine (P < 0.0001; r = −0.64); rebound pain was not directly tested, differences in the timing of rescue analgesia could not be excluded, and this finding complicates the interpretation of the early benefit. In exploratory secondary analyses not adjusted for multiplicity, intraoperative fentanyl consumption (P = 0.0052) and estimated isoflurane consumption (P < 0.0001; vaporiser estimates without gas analysis) were lower, and time to first opioid request was longer (P < 0.0001; r = −0.89). Fentanyl was analysed as total dose only, isoflurane was confounded by longer surgical duration, and these findings are exploratory. Cumulative postoperative opioid consumption at 12 and 24 hours was not measured; a longer time to first request does not equate to reduced total opioid exposure. Blood loss did not differ (P = 0.561). No clinically apparent local anaesthetic systemic toxicity, vascular puncture, pneumothorax, or block-related complications occurred, but haemodynamic changes attributable to epinephrine were not systematically recorded, and safety in patients with cardiovascular comorbidity requires investigation.

Conclusions

Adding epinephrine to ropivacaine for ESPB produced a statistically significant but modest early reduction in pain that was below the MCID; the trial was negative for a clinically important primary endpoint and did not provide unequivocal evidence of clinical benefit. The borderline adjusted result and wide confidence interval indicate uncertainty. Secondary findings are exploratory and hypothesis-generating and do not provide independent confirmation. The exploratory finding of higher pain at 12 hours may reflect rebound or differential rescue exposure and complicates the early benefit; net clinical benefit remains uncertain. Surgical procedure data were not collected; baseline imbalances despite randomization and the small sample limit the robustness of the findings, and residual confounding cannot be excluded. The modified intention-to-treat analysis excluded five patients; a full intention-to-treat analysis was not feasible. The optimal epinephrine dose remains uncertain. Epinephrine is a simple, low-cost adjuvant; larger confirmatory studies are needed.

Zitieren

APA

Nashibi, M., Asgari, S., Mottaghi, K., Ahmadi, H. A., Moghbel, M., Pourakbari, S., & Hosseininasab, S. (2026). Epinephrine as an Adjuvant to Ropivacaine for Erector Spinae Plane Block in Lumbar Spine Surgery: A Randomized, Double-Blind, Controlled Trial. Archives of Neuroscience, 13(3). https://doi.org/10.5812/ans-175329

Vancouver

Nashibi M, Asgari S, Mottaghi K, Ahmadi HA, Moghbel M, Pourakbari S, et al. Epinephrine as an Adjuvant to Ropivacaine for Erector Spinae Plane Block in Lumbar Spine Surgery: A Randomized, Double-Blind, Controlled Trial. Archives of Neuroscience. 2026;13(3). doi:10.5812/ans-175329

BibTeX
@article{Nashibi2026,
  author = {Nashibi, Masoud and Asgari, Sogol and Mottaghi, Kamran and Ahmadi, Hasan Ali and Moghbel, Maryam and Pourakbari, Shiva and Hosseininasab, Sam},
  title = {Epinephrine as an Adjuvant to Ropivacaine for Erector Spinae Plane Block in Lumbar Spine Surgery: A Randomized, Double-Blind, Controlled Trial},
  journal = {Archives of Neuroscience},
  year = {2026},
  volume = {13},
  number = {3},
  doi = {10.5812/ans-175329}
}
Kostenlos starten →